Your browser doesn't support javascript.
loading
A systematic review of whether COVID-19 randomized controlled trials reported on demographic and clinical characteristics.
Pak, Joyce; Lund, Jennifer L; Keil, Alexander; Westreich, Daniel; Stürmer, Til; Wohl, David; Farel, Claire; Drummond, M Bradley; Webster-Clark, Michael.
Afiliación
  • Pak J; Department of Epidemiology, UNC Gillings School of Global Public health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Lund JL; Department of Epidemiology, UNC Gillings School of Global Public health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Keil A; Department of Epidemiology, UNC Gillings School of Global Public health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Westreich D; Department of Epidemiology, UNC Gillings School of Global Public health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Stürmer T; Department of Epidemiology, UNC Gillings School of Global Public health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Wohl D; Department of Medicine, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Farel C; Department of Medicine, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Drummond MB; Department of Medicine, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Webster-Clark M; Department of Epidemiology, UNC Gillings School of Global Public health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Pharmacoepidemiol Drug Saf ; 31(12): 1219-1227, 2022 12.
Article en En | MEDLINE | ID: mdl-35996832

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Aged80 / Humans Idioma: En Revista: Pharmacoepidemiol Drug Saf Asunto de la revista: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Aged80 / Humans Idioma: En Revista: Pharmacoepidemiol Drug Saf Asunto de la revista: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos